Teva Pharmaceutical Industries
TEVA
$16.31
Share price
1.87%
Change (1 day)
-0.43%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Total debt
Total debt on the balance sheet as of March 2025 : $16.93 Billion USD
According to Teva Pharmaceutical Industries's latest financial reports the company's total debt is $16.93 Billion USD. A company’s total debt is the sum of all current and non-current debts.
Teva Pharmaceutical Industries - Total debt on balance sheet (from 1996 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | $18.07 B | -10.29% |
| 2023-12-31 | $20.15 B | -6.53% |
| 2022-12-31 | $21.56 B | -8.09% |
| 2021-12-31 | $23.45 B | -11.13% |
| 2020-12-31 | $26.39 B | -3.45% |
| 2019-12-31 | $27.34 B | -5.44% |
| 2018-12-31 | $28.91 B | -10.96% |
| 2017-12-31 | $32.47 B | -9.29% |
| 2016-12-31 | $35.80 B | 260.05% |
| 2015-12-31 | $9.94 B | -3.72% |
| 2014-12-31 | $10.32 B | -15.29% |
| 2013-12-31 | $12.19 B | -17.17% |
| 2012-12-31 | $14.71 B | 1.39% |
| 2011-12-31 | $14.51 B | 110.96% |
| 2010-12-31 | $6.88 B | 22.61% |
| 2009-12-31 | $5.61 B | -33.53% |
| 2008-12-31 | $8.44 B | 62.74% |
| 2007-12-31 | $5.18 B | -2.61% |
| 2006-12-31 | $5.32 B | 147.88% |
| 2005-12-31 | $2.14 B | 3.67% |
| 2004-12-31 | $2.07 B | 42.03% |
| 2003-12-31 | $1.45 B | -23.17% |
| 2002-12-31 | $1.89 B | 30.72% |
| 2001-12-31 | $1.45 B | 25.79% |
| 2000-12-31 | $1.15 B | 73.05% |
| 1999-12-31 | $0.66 B | 26.89% |
| 1998-12-31 | $0.52 B | 42.33% |
| 1997-12-31 | $0.36 B | -26.4% |
| 1996-12-31 | $0.50 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $31.27 B | 84.60% | 🇨🇭 Switzerland |
 Sanofi SNY | $22.77 B | 34.43% | 🇫🇷 France |
 GlaxoSmithKline GSK | $23.81 B | 40.60% | 🇬🇧 UK |
 Pfizer PFE | $61.29 B | 261.83% | 🇺🇸 USA |
 Merck MRK | $34.84 B | 105.70% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | $0.54 B | -96.77% | 🇮🇳 India |
 AstraZeneca AZN | $31.29 B | 84.75% | 🇬🇧 UK |